脏缩:对当前设备,技术和证据的审查
Monica Tung1, Taisei Kobayashi2, Rajesh V Swaminathan3
1Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Interventional cardiology clinics
|March 6, 2025
概括
通过导管脏缩为高血压提供了一种新的治疗方法,通过向交感神经系统. 这种程序为患有失控高血压的患者提供了持久的好处,安全问题最小.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 高血压显著导致美国的发病率和死亡率.
- 管理高血压仍然是一个临床挑战.
- 交感神经系统过度活跃在高血压中起着关键作用.
研究的目的:
- 为了评估透管脏缩作为高血压的辅助疗法.
- 评估未控制高血压患者脏化的疗效和安全性.
- 对于无法或不愿意使用抗高血压药物的患者来说,探索脏化.
主要方法:
- 使用过导管脏缩,准交感神经.
- 使用了使用射频剥离和超声波能量的设备.
- 在3年的时间内评估治疗效果和安全性.
主要成果:
- 经管性损显示治疗效果可持续长达3年.
- 射频和超声波设备都显示出持续的好处.
- 观察到与设备相关的安全问题很少.
结论:
- 透管性损是治疗失控高血压的有效补充治疗方法.
- 这种微创方法为药物不耐受或耐药患者提供了可行的选择.
- 脏皮表现出有利的长期安全性.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K